Postoperative radiotherapy after prostatectomy: A review

Scandinavian Journal of Urology and Nephrology

Volumn 37, Issue 1, 2003, Pages 10-15

  Lennernäs, Bo ^a   Edgren, Maliha ^a   Häggman, Michael ^b   Norlén, Bo J ^b   Nilsson, Sten ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Irradiation; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; EDEMA; HUMAN; IRRADIATION; MALE; METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; REVIEW; RISK FACTOR; SEMINAL VESICLE DISEASE; TIME; URETHRA STRICTURE;

ADENOCARCINOMA; HUMANS; MALE; POSTOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0037285289     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310008613     Document Type: Review

References (45)

1. Paulson DF, Robertson CN. Positive margins: is adjunctive radiation therapy indicated. Acta Oncol 1991; 30: 263-5.
2. Eisbruch A, Perez CA, Roessler EH, Lockett MA. Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 1994; 73: 384-7.
3. Schild SE, Wong WW, Grado Gl et al. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996; 34: 535-41.
4. Zietman AL, Coen JJ, Shipley WU, Althausen AF. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of the prostate: analysis of freedom from PSA failure. Urology 1993; 42: 292-9.
5. Link P, Freiha FS, Stamey TA. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 1991; 145: 532-4.
6. Conolly JA, Presti JC Jr, Cher ML, Chew K, Shiohara K, Carroll PR. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Uron 1997; 158: 515-8.
7. George FW, Carlton CE, Dykhuizen RF, Dillon JR. Cobalt-60 telecurietherapy in the definitive treatment of carcinomas of the prostate: a preliminary report. J Urol 1965; 93: 102.
8. Ray GR, Cassady JR, Bagshaw MA. External-beam magavoltage radiation treatment of post-radical prostatectomy residual or recurrent tumor: Preliminary results. J Urol 1975; 114: 98-101.
9. Ray GR, Bagshaw MA, Freiha FS. External beam irradiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 1984; 132: 926-30.
10. Forman JD, Meetze K, Pontes E, Wood DP, Shamsa F, Rana T, et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 1997; 158: 1436-40.
11. Schild ES. Radiation therapy after prostatectomy: Now or later. Sem Radiat Oncol 1998; 8: 132-9.
12. Anscher MS, Robertson CN, Prosnitz R. Adjuvant radiotherapy for pathologic stage PT3/4 adenocarcinoma of the prostate: ten-year update. Int J Radiat Oncol Biol Phys 1995; 33: 37-43.
13. Morgan WR, Zinke H, Rainwater LM, Mayers RP, Klee GG. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 1991; 145: 319-23.
14. Morris MM, Dallow KC, Zietman AL, et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 731-36.
15. Petrovich Z, Lieskovsky G, Langholz B, Formenti S, Baert L, Streeter O, et al. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (PT3) carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1998; 40: 139-47.
16. Perez CA. Prostate. In Principles and practice of radiation oncology. Perez CA, Brady LW (Eds). JB Lippincott Company, Philadelphia 1992, pp. 1067-1116.
17. Cheng WS, Fryndenberg M, Bergstrahl EJ. Larsson-Keller JJ, Zincke H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 1993; 42: 283-91.
18. Meier R, Mark R, St Royal L, Tran L, Colburn G, Parker R. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 1992; 70: 1960-66.
19. Gibbons RP, Cole BS, Richardson RG, et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Uron 1986; 135: 65-8.
20. Paulson DF, Moul JW, Robertson JE, Walther PJ. Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1990; 143: 1178-83.
21. Mukarnel E, deKernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 1987; 59: 1535-8.
22. Jhaveri FM, Zippe CD, Klein EA, Kupelian PA. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10 year results. Urology 1999; 54: 884-90.
23. Roach M III. The role of PSA in radiotherapy of prostatic cancer. Oncology Huntingt 1996;10:1143-61.
24. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostatic cancer. Int J Radiat Oncon Biol Phys 1988; 15: 1299-305.
25. Nudell DM, Grossfeld GD, Weinberg VK, Roach M III, Carroll PR. Radiotherapy after radical prostatectomy: treatments outcomes and failure patterns. Urology 1999; 54:1049-57.
26. D'Amigo AV, Whittington R, Malkowics SB, Schultz D, Tomaszewski JE, Wein A. Prostate-specific antigen failure despite pathologically organ-defined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 1997; 15: 465-9.
27. McCarthy JF, Catalona WJ, Hudson MA. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Uron 1994; 151: 1575-78.
28. Grossfeld GD, Tigrani VS, Nudell D, Roach M III, Weinberg VK, Presti JC Jr, Small EJ. Management of a positive surgical margin after radical prostatectomy: decision analysis. J Urol 2000; 164: 93-9.
29. Schild SE. Radiation therapy after prostatectomy: the case for salvage therapy as opposed to adjuvant therapy. Int J Cancer 2001; 96: 94-8.
30. Anscher MS. Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic then salvage radiotherapy for a rising prostate specific antigen. Int J Cancer 2001; 96: 91-3.
31. Van Poppel H, Vanuytsel L, Petrovich Z, et al. Current controversis in cancer. Is postoperative irradiation after radical prostatectomy necessary. Eur J Cancer 1999; 35: 1763-70.
32. Petrovich Z, Lieskovsky G, Langholz B, Luxton G, Jozef G, Skinner DG. Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1991; 21: 949-54.
33. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Uron 1989; 142: 332-6.
34. Bagshaw MA, Radiotherapeutic treatment of prostatic carcinoma with pelvic node involvement. Urol Clin N Am 1984; 11: 297-303.
35. Valecenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42: 501-6.
36. Forman JD, Wharam MD, Lee DJ, Zinreich ES, Order SE. Definitive radiotherapy following prostatectomy: Results and complications. Int J Radiat Oncol Biol Phys 1986; 12: 185-9.
37. Lange PH, Moon TD, Narayan P, Medini E. Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results. J Urol 1986; 136: 45-9.
38. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141: 873-9.
39. Lange PH, Lightner DJ, Medici E, Reddy PK, Vesella RL. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 1990; 144: 927-33.
40. Piepich MV, Walz BJ, Baglan RJ. Postoperative irradiation in carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1984; 10: 1869-73.
41. Wiegel T, Bressel M, Arps H, Hubener KH. Radiotherapy of local recurrence following radical prostatectomy. Strahlenther Oncol 1992; 168: 333-6.
42. Catton C, Gospodarowics M, Warde P, Panzarella T, Catton P, McLean M, et al. Adjuvant and salvage radiation therapy after radical prostataectomy for adenocarcinoma of the prostate. Rad Oncol 2001; 59: 51-60.
43. Edgren M, Lennernas B, Haggman M, Norlen BJ, Nilsson S. Postoperative radiotherapy after prostatectomy can be associated with severe side effects. Anticancer Res 2001; 21(3C): 2231-5.
44. Lennernäs B, Letocha H, Rikner G, Magnusson A, Nilsson S. Field displacement during external radiotherapy in prostatic adenocarcinoma treated with radioactive 198-Au implants and external irradiation. Acta Oncol 1995; 34: 959-64.
45. Ornstein DK, Colberg JW, Virgo KS, Chan D, Johnson ET, Oh J, et al. Evaluation and management of men whose radical prostatectomies failed: Results of an international survey. Urology 1998; 52: 1047-54.